Chanthima Phuriphong, Yuwapattanawong Kornkamon, Thamjamrassri Thanyalak, Nathwani Rajen, Stansbury Lynn G, Vavilala Monica S, Arbabi Saman, Hess John R
From the Harborview Injury Prevention and Research Center, Seattle, Washington.
Department of Anesthesiology and Pain Medicine University of Washington, School of Medicine, Seattle, Washington.
Anesth Analg. 2021 Jun 1;132(6):1684-1691. doi: 10.1213/ANE.0000000000005431.
Transfusion of citrated blood products may worsen resuscitation-induced hypocalcemia and trauma outcomes, suggesting the need for protocolized early calcium replacement in major trauma. However, the dynamics of ionized calcium during hemostatic resuscitation of severe injury are not well studied. We determined the frequency of hypocalcemia and quantified the association between the first measured ionized calcium concentration [iCa] and calcium administration early during hemostatic resuscitation and in-hospital mortality.
We performed a retrospective cohort study of all admissions to our regional level 1 trauma center who (1) were ≥15 years old; (2) presented from scene of injury; (3) were admitted between October 2016 and September 2018; and (4) had a Massive Transfusion Protocol activation. They also (1) received blood products during transport or during the first 3 hours of in-hospital care (1st3h) of trauma center care and (2) had at least one [iCa] recorded in that time. Demographic, injury severity, admission shock and laboratory data, blood product use and timing, and in-hospital mortality were extracted from Trauma Registry and Transfusion Service databases and electronic medical records. Citrate load was calculated on a unit-by-unit basis and used to calculate an administered calcium/citrate molar ratio. Univariate and multivariable logistic regression analyses for the binary outcome of in-hospital death were performed.
A total of 11,474 trauma patients were admitted to the emergency department over the study period, of whom 346 (3%; average age: 44 ± 18 years; 75% men) met all study criteria. In total, 288 (83.2%) had hypocalcemia at first [iCa] determination; 296 (85.6%) had hypocalcemia in the last determination in the 1st3h; and 177 (51.2%) received at least 1 calcium replacement dose during that time. Crude risk factors for in-hospital death included age, injury severity score (ISS), new ISS (NISS), Abbreviated Injury Scale (AIS) head, admission systolic blood pressure (SBP), pH, and lactate; all P < .001. Higher in-hospital mortality was significantly associated with older age, higher NISS, AIS head, and admission lactate, and lower admission SBP and pH. There was no relationship between mortality and first [iCa] or calcium dose corrected for citrate load.
In our study, though most patients had hypocalcemia during the 1st3h of trauma center care, neither first [iCa] nor administered calcium dose corrected for citrate load were significantly associated with in-patient mortality. Clinically, hypocalcemia during early hemostatic resuscitation after severe injury is important, but specific treatment protocols must await better understanding of calcium physiology in acute injury.
输注枸橼酸盐血液制品可能会加重复苏诱导的低钙血症及创伤结局,这表明在严重创伤中需要制定早期钙剂补充方案。然而,严重损伤止血复苏过程中离子钙的动态变化尚未得到充分研究。我们确定了低钙血症的发生率,并量化了首次测得的离子钙浓度[iCa]与止血复苏早期钙剂使用及院内死亡率之间的关联。
我们对所有入住本地区一级创伤中心的患者进行了一项回顾性队列研究,这些患者需满足以下条件:(1)年龄≥15岁;(2)从受伤现场送来;(3)于2016年10月至2018年9月期间入院;(4)启动了大量输血方案。他们还需满足:(1)在转运过程中或创伤中心治疗的院内护理的前3小时(第1个3小时)接受了血液制品;(2)在该时间段内至少记录了一次[iCa]。从创伤登记处、输血服务数据库及电子病历中提取人口统计学、损伤严重程度、入院时休克及实验室数据、血液制品使用情况及时间,以及院内死亡率。按单位计算枸橼酸盐负荷,并用于计算钙剂/枸橼酸盐给药摩尔比。对院内死亡这一二元结局进行单变量及多变量逻辑回归分析。
在研究期间,共有11474例创伤患者入住急诊科,其中346例(3%;平均年龄:44±18岁;75%为男性)符合所有研究标准。总共288例(83.2%)在首次[iCa]测定时存在低钙血症;296例(85.6%)在第1个3小时的最后一次测定时存在低钙血症;177例(51.2%)在该时间段内接受了至少一剂钙剂补充。院内死亡的粗风险因素包括年龄、损伤严重程度评分(ISS)、新损伤严重程度评分(NISS)、简明损伤定级(AIS)头部评分、入院收缩压(SBP)、pH值及乳酸水平;所有P<0.001。较高的院内死亡率与年龄较大、NISS较高、AIS头部评分较高及入院时乳酸水平较高,以及入院SBP及pH值较低显著相关。死亡率与首次[iCa]或校正枸橼酸盐负荷后的钙剂剂量之间无关联。
在我们的研究中,尽管大多数患者在创伤中心护理的第1个3小时内存在低钙血症,但首次[iCa]及校正枸橼酸盐负荷后的钙剂给药剂量均与住院死亡率无显著关联。临床上,严重损伤后早期止血复苏期间的低钙血症很重要,但具体治疗方案必须等待对急性损伤中钙生理学有更好的了解。